U.S. Life Sciences Stock News

Puma Biotechnology (PBYI) closed FY 2025 with Q4 revenue of US$75.5 million and basic EPS of US$0.27, alongside net income of US$13.4 million. Its trailing 12 month revenue came in at US$228.4 million with basic EPS of US$0.62 and net income of US$31.1 million. Over recent periods, the company has seen quarterly revenue range from US$46.0 million to US$80.5 million and basic EPS move between US$0.06 and US$0.98. This gives investors a clear view of how earnings scale with top line...

Emergent BioSolutions (EBS) has just wrapped up FY 2025 with Q4 revenue of US$148.7 million and basic EPS of a US$1.04 loss, capping a year in which quarterly revenue ranged from US$140.9 million to US$231.1 million and EPS swung between a profit of US$1.25 and a loss of US$0.22. Over the trailing 12 months to Q4 2025, the company recorded total revenue of US$742.9 million and basic EPS of US$0.98. This leaves investors to weigh improving headline profitability alongside still uneven...

Recent analyst commentary on V.F (VFC) has focused on weakness at the Vans brand, with J.P. Morgan issuing a downgrade that questions how quickly the company can reach its stated operating margin goals. See our latest analysis for V.F. The latest analyst downgrade comes after a mixed year for investors, with a 10.97% 90 day share price return and a 6.94% year to date share price return, in contrast with a 20.33% 1 year total shareholder return decline. This suggests that recent momentum has...

PRA Group (PRAA) closed out FY 2025 with Q4 revenue of US$333.4 million and basic EPS of US$1.46, while the trailing 12 month picture shows total revenue of about US$1.2 billion and a basic EPS loss of US$7.79. The company has seen quarterly revenue move from US$293.2 million in Q4 2024 to US$333.4 million in Q4 2025, with basic EPS shifting from US$0.47 to US$1.46 over the same period, alongside a wider loss on a trailing 12 month basis of US$305.1 million. Margins look compressed on the...

If you are wondering whether Southwest Gas Holdings at around US$88 per share offers good value today, you are not alone; many investors are trying to work out what a fair price looks like. The stock has returned 0.7% over the last week, 7.6% over the past month, 10.0% year to date, 21.3% over one year, 62.5% over three years and 51.5% over five years, which naturally raises questions about how its current price lines up with its fundamentals. Recent news flow around regulated utilities, gas...

United Natural Foods (NYSE:UNFI) hosted its 2026 Spring and Summer Selling Show, bringing together thousands of retailers and suppliers. The company unveiled nearly 50 new private label products across categories at the event. Key themes included healthier food offerings, private brand development, and growing interest in gut health. For you as an investor, this matters because UNFI sits at the center of the natural, specialty, and conventional grocery supply chain, connecting brands with...

FTI Consulting (FCN) has wrapped up FY 2025 with fourth quarter revenue of US$990.7 million and basic EPS of US$1.80, closing out a year where trailing twelve month revenue reached about US$3.8 billion and EPS came in at US$8.33. The company has seen revenue move from US$894.9 million in Q4 2024 to US$990.7 million in Q4 2025, while quarterly EPS shifted from US$1.41 to US$1.80. This may set the stage for investors to focus on how its 7.1% net margin and forecast earnings growth shape the...

If you are wondering whether F.N.B at around US$16.99 is still offering value, you are not alone. This article is built to help you make sense of where the stock stands on price versus fundamentals. The share price has seen mixed moves recently, with a 7 day return of 7.3% decline, a 30 day return of 1.4% decline, but a 1 year return of 18.1% and a 5 year return of 60.0%, which can change how investors think about both potential growth and risk. Recent coverage of regional banks and funding...

Howmet Aerospace (NYSE:HWM) announced a plan to acquire Consolidated Aerospace Manufacturing (CAM). The company intends to fund the deal using proceeds from a mix of newly announced and completed debt offerings. The transaction is expected to influence Howmet's operations, market positioning, and capital structure once finalized. Howmet Aerospace, a key supplier of engineered components for aerospace and industrial markets, is moving to expand its footprint with the CAM acquisition. For you...

Recently, D.R. Horton reiterated its full-year 2026 guidance but faced pressure as cautious housing-demand signals weighed on homebuilder sentiment. Analysts have turned more pessimistic on the company ahead of its April 21, 2026 earnings release, reflecting growing concern over sector headwinds. Next, we’ll examine how weakening housing-demand signals and more cautious analyst views may influence D.R. Horton’s existing investment narrative. The best AI stocks today may lie beyond giants...

Sprout Social (SPT) closed out FY 2025 with Q4 revenue of US$120.9 million and a basic EPS loss of US$0.18, while trailing twelve month figures show revenue of US$457.5 million and a basic EPS loss of US$0.73. Over recent quarters the company has seen revenue move from US$102.6 million in Q3 2024 to US$120.9 million in Q4 2025, with quarterly basic EPS losses ranging between US$0.16 and US$0.30, which keeps the focus firmly on how quickly the business can narrow those losses and improve...

Kymera Therapeutics (KYMR) closed FY 2025 with Q4 revenue of US$2.9 million and a basic EPS loss of US$0.97, while full year trailing twelve month figures showed revenue of US$39.2 million and a basic EPS loss of US$3.69. The company reported a decline in quarterly revenue from US$22.1 million in Q1 2025 to US$2.9 million in Q4, while basic EPS losses ranged between US$0.82 and US$0.97 across the year. This has set up a results season in which investors are weighing growth potential against...

Somnigroup International (SGI) came under pressure after its fourth quarter results and a new dividend declaration, as revenue missed analyst expectations even though sales and earnings for the period were higher than a year earlier. See our latest analysis for Somnigroup International. The fourth quarter earnings and dividend announcement came after a period where the share price has cooled slightly, with a 1-day share price return showing a 1.76% decline and a 90-day share price return...

Xylem (NYSE:XYL) has authorized a new share repurchase program of up to $1.5b. The program allows the company to buy back shares opportunistically over time. The announcement comes with Xylem shares recently trading around $129.56. Xylem, trading on the NYSE under the ticker XYL, is moving ahead with a sizeable $1.5b buyback plan at a share price of about $129.56. Over the past 3 years, the stock has returned 29.3%, and 37.1% over 5 years, which gives context for how management is choosing...

Hagerty (HGTY) closed FY 2025 with Q4 revenue of US$357.3 million and basic EPS of US$0.07, alongside Q4 net income of US$6.9 million. On a trailing twelve month basis, revenue was US$1.5 billion, EPS was US$0.44 and net income was US$41.5 million. Over the last few quarters the company has seen revenue move from US$291.7 million and EPS of US$0.01 in Q4 FY 2024 to US$379.9 million and EPS of US$0.18 in Q3 FY 2025, before landing at the latest Q4 figures. This sets up a story where higher...

Why Houlihan Lokey (HLI) is on investors’ radar today Houlihan Lokey (HLI) has drawn fresh attention after recent share price pressure, with the stock showing a 3.2% decline over the past day and a 9.3% pullback over the past month. See our latest analysis for Houlihan Lokey. That recent 9.3% 1 month share price decline and 7.1% year to date share price pullback sit against a much stronger long run picture, with 3 year total shareholder return of 79.1% and 5 year total shareholder return of...

Willdan Group (WLDN) capped FY 2025 with fourth quarter revenue of US$173.7 million and basic EPS of US$1.28, while trailing twelve month revenue reached US$681.6 million with EPS of US$3.63 as earnings over the last year were reported to have grown 131.8%. Over the past six quarters the company has seen quarterly revenue range from US$144.1 million to US$182.0 million, with basic EPS between US$0.33 and US$1.28. This sets up a story where improving net profit margin to 7.7% from 4% and high...

Vertex, Inc. recently reported past Q4 2025 results showing 9.1% year-over-year revenue growth, outlined 2026 guidance calling for US$823.5–US$831.5 million in revenue with 25% cloud growth, and announced a US$150 million share buyback alongside ongoing AI-enabled tax compliance expansion. Investor attention is also being drawn to a director’s recent open-market share purchase and management’s outlook for continued double-digit revenue growth and improving profit margins, which together...

Shift4 Payments (FOUR) has wrapped up FY 2025 with Q4 revenue of US$1.2b and basic EPS of US$0.37, alongside net income of US$25m that keeps the spotlight firmly on how efficiently each transaction is translating into profit. The company has seen quarterly revenue move from US$909.2m in Q3 2024 to US$848.3m in Q1 2025 and then up to US$1.2b in Q4 2025, while basic EPS shifted from US$0.78 in Q3 2024 to US$0.24 in Q1 2025 and US$0.37 in the latest quarter, setting the stage for investors to...

Starz Entertainment (STRZ) opened Q3 2026 with revenue of US$322.8 million and a basic EPS loss of US$1.24, with trailing twelve month EPS at a loss of US$16.16 on revenue of US$1.3 billion. Over recent quarters, the company has seen quarterly revenue move from US$346.9 million in Q2 2025 to US$344.5 million in Q3 2025, US$330.6 million in Q4 2025, and then settle around US$320.3 million to US$322.8 million across the first three quarters of 2026, while basic EPS losses shifted between...

Xenon Pharmaceuticals (XENE) has put fresh numbers on the table for FY 2025, with first half revenue at US$7.5 million and a basic EPS loss of US$1.90, alongside a trailing twelve month EPS loss of US$4.36. The company has seen revenue move from US$0 in both halves of 2024 to US$7.5 million in the latest half. Basic EPS losses widened from US$1.36 and US$1.64 in the first and second halves of 2024 to US$1.90 most recently and a trailing twelve month net loss of US$345.91 million, keeping...

If you are wondering whether Redwire's share price still reflects its underlying worth, this article will walk through what the current numbers might be telling you about value and risk. The stock last closed at US$9.07, with recent returns ranging from a 13.5% gain over 7 days to a 31.8% decline over 30 days, and a 35.1% decline over the past year, while the 3 year return sits at a very large gain. Recent news around Redwire has focused on its role in the space and defense sectors,...

Gogo (GOGO) closed out FY 2025 with Q4 revenue of US$230.6 million and a basic EPS loss of US$0.07, as investors weighed the latest headline numbers against a still modest trailing profit base. The company has seen quarterly revenue range from US$223.6 million to US$230.6 million across 2025, while basic EPS moved from a profit of US$0.09 in Q1 and US$0.10 in Q2 to small losses of US$0.01 in Q3 and US$0.07 in Q4, creating a mixed picture on earnings momentum and margins. See our full analysis...

Organogenesis Holdings (ORGO) has capped FY 2025 with fourth quarter revenue of US$225.6 million and basic EPS of US$0.28, with trailing twelve month revenue at US$564.2 million and basic EPS of US$0.16. Over recent periods the company has seen quarterly revenue move from US$126.7 million in Q4 2024 to US$225.6 million in Q4 2025, while quarterly EPS shifted from US$0.05 to US$0.28 over the same span, as trailing twelve month EPS moved from roughly breakeven at US$0.01 to US$0.16. For...